The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury
- PMID: 31787098
- PMCID: PMC6886173
- DOI: 10.1186/s12929-019-0587-9
The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury
Abstract
Background: Insulin-like growth factor 1 (IGF-1) is an important pleiotropic hormone that exerts neuroprotective and neuroreparative effects after a brain injury. However, the roles of IGF-1 variants in mild traumatic brain injury (mTBI) are not yet fully understood. This study attempted to elucidate the effects of IGF-1 variants on the risk and neuropsychiatric outcomes of mTBI.
Methods: Based on 176 recruited mTBI patients and 1517 control subjects from the Taiwan Biobank project, we first compared the genotypic distributions of IGF-1 variants between the two groups. Then, we analyzed associations of IGF-1 variants with neuropsychiatric symptoms after mTBI, including anxiety, depression, dizziness, and sleep disturbances. Functional annotation of IGF-1 variants was also performed through bioinformatics databases.
Results: The minor allele of rs7136446 was over-represented in mTBI patients compared to community-based control subjects. Patients carrying minor alleles of rs7136446 and rs972936 showed more dizziness and multiple neuropsychiatric symptoms after brain injury.
Conclusions: IGF-1 variants were associated with the risk and neuropsychiatric symptoms of mTBI. The findings highlight the important role of IGF-1 in the susceptibility and clinical outcomes of mTBI.
Keywords: Anxiety; Depression; Dizziness; Genetic variants; Insulin-like growth factor 1; Mild traumatic brain injury; Sleep disorders.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- James SL, Theadom A, Ellenbogen RG, Bannick MS, Montjoy-Venning W, Lucchesi LR, et al. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):56–87. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- MOST 104-2923-B-038-004-MY2/Ministry of Science and Technology (TW)
- MOST105-2628-B-038-001-MY4/Ministry of Science and Technology, Taiwan
- MOHW105-TDU-B-212-133018/Ministry of Health and Welfare (TW)
- 08A1-MGGP08-037/National Health Research Institutes
- DP2-108-21121-01-N-05-01/Taipei Medical University (TW)
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous